Hongchang International Co., Ltd

HCIL ·Healthcare, Medical Devices
Financial Statements Cash Flow Statement
Annual Quarterly

Cash Flow Statement

Line Item Dec 2025 Sep 2025 Jun 2025 Mar 2025 Dec 2024 Sep 2024 Jun 2024 Mar 2024
Operating Activities
Net Income $304.3K $198.2K $499.9K $1.5M $-309.4K $-61.1K $-64.8K $-96.6K
Depreciation & Amortization $204.8K $190.9K $188.7K $134.1K $23.3K $23.4K $21.8K $22.1K
Depreciation $182.1K $168.6K $166.5K $112.6K $1.7K $1.6K $275 $279
Amortization $81 $81 $81 $81
Stock-Based Compensation
Net Cash from Operating Activities $-316.0K $-95.5K $-229.8K $2.8M $2.3M $409.2K $-3.1M $9.7K
Investing Activities
Capital Expenditures $305.2K $416.1K $135.6K $139.5K $86.7K $4.6M $75.5K $6.1M
Business Acquisitions $-65.4K
Net Cash from Investing Activities $-305.2K $-416.1K $-135.6K $1.1M $-659.1K $-4.6M $-75.5K $-5.0M
Financing Activities
Dividends Paid
Stock Repurchases
Net Cash from Financing Activities $1.1M $494.7K $-79.9K $-3.4M $-1.7M $4.2M $2.6M $5.1M
Net Change in Cash $523.3K $-16.1K $-440.4K $470.3K $-66.5K $-10.3K $-577.7K $-656
Free Cash Flow $-621.2K $-511.6K $-365.4K $2.6M $2.2M $-4.2M $-3.2M $-6.1M
← Newer Page 1 of 8 Older →